Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity
- PMID: 9626621
- DOI: 10.1359/jbmr.1998.13.6.911
Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity
Abstract
Paget's disease of bone is a common condition characterized by bone pain, deformity, pathological fracture, and an increased incidence of osteosarcoma. Genetic factors play a role in the pathogenesis of Paget's disease but the molecular basis of the disease remains unclear. Previous genetic linkage studies have mapped the rare Paget's disease-like bone dysplasia familial expansile osteolysis (FEO) to chromosome 18q21-22, and recent work has shown evidence of linkage between this locus and Paget's disease in one family. Here we studied the relationship between the 18q21-22 locus and Paget's disease in eight large multiplex families from diverse ethnic backgrounds with inherited Paget's disease. Paget's disease was inherited as an autosomal dominant trait in all families, with high penetrance by the sixth decade. Analysis of seven highly polymorphic markers from chromosome 18q21-22 showed positive summated two-point log10 odds ratio (lodscores) of +2.97 with the marker D18S42 at a recombination fraction (theta) = 0.05, and of +2.95 with the marker D18S60 at theta = 0.00, values which are close to the cut-off of +3.0, which is generally accepted as evidence of linkage. Segregation analysis of the haplotypes and formal statistical analysis using the HOMOG program provided evidence for genetic heterogeneity, however, with evidence for linkage in five families and against linkage in the remaining three families (chi square 8.82; df = 2; p < 0.025). Multipoint linkage analysis in the five linked families showed lodscores of above +3.5 across the whole susceptibility region and a maximum summated lodscore of 3.89 at the marker D18S465. In the three nonlinked families, negative multipoint results were obtained for the whole region, with lodscores below -2.0 in one family, excluding this as a candidate locus for the disease. Our studies demonstrate the importance of hereditary factors in the pathogenesis of Paget's disease and confirm evidence of linkage between Paget's disease and chromosome 18q21-22 in some families. This raises the possibility that Paget's disease and FEO may share a common molecular basis, perhaps due to different mutations in the same gene or family of genes. Data from three families did not support evidence of linkage to 18q21-22 however, indicating that Paget's disease is genetically heterogeneous and suggests the presence of at least one additional locus which remains to be discovered.
Similar articles
-
Familial Paget's disease of bone: nonlinkage to the PDB1 and PDB2 loci on chromosomes 6p and 18q in a large pedigree.J Bone Miner Res. 2001 Jan;16(1):33-8. doi: 10.1359/jbmr.2001.16.1.33. J Bone Miner Res. 2001. PMID: 11149487
-
Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q.Bone. 2000 Jun;26(6):577-80. doi: 10.1016/s8756-3282(00)00278-7. Bone. 2000. PMID: 10831928
-
Inheritance of osteosarcoma and Paget's disease of bone: a familial loss of heterozygosity study.J Mol Diagn. 2001 Nov;3(4):171-7. doi: 10.1016/S1525-1578(10)60669-1. J Mol Diagn. 2001. PMID: 11687601 Free PMC article.
-
Common mechanisms of osteosarcoma and Paget's disease.J Bone Miner Res. 1999 Oct;14 Suppl 2:39-44. doi: 10.1002/jbmr.5650140209. J Bone Miner Res. 1999. PMID: 10510212 Review.
-
Genetics of Paget's disease of bone.Joint Bone Spine. 2006 May;73(3):243-8. doi: 10.1016/j.jbspin.2005.05.009. Epub 2006 Jan 18. Joint Bone Spine. 2006. PMID: 16574459 Review.
Cited by
-
Paget's disease with craniofacial and skeletal bone involvement.BMJ Case Rep. 2016 Sep 1;2016:bcr2016216173. doi: 10.1136/bcr-2016-216173. BMJ Case Rep. 2016. PMID: 27587747 Free PMC article.
-
Paget disease of bone.J Clin Invest. 2005 Feb;115(2):200-8. doi: 10.1172/JCI24281. J Clin Invest. 2005. PMID: 15690073 Free PMC article. Review.
-
Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).J Cell Physiol. 2009 Dec;221(3):778-88. doi: 10.1002/jcp.21921. J Cell Physiol. 2009. PMID: 19746444 Free PMC article.
-
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?BMC Health Serv Res. 2006 Jun 8;6:71. doi: 10.1186/1472-6963-6-71. BMC Health Serv Res. 2006. PMID: 16762063 Free PMC article.
-
The genetics of osteosarcoma.Sarcoma. 2012;2012:627254. doi: 10.1155/2012/627254. Epub 2012 May 20. Sarcoma. 2012. PMID: 22685381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous